Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by ramrodretired on Nov 23, 2020 8:09pm

WELL FINALLY

Great posts today LADS(just like a real bullboard)
Comment by Pandora on Nov 24, 2020 5:47pm
A Canadian covid story - it's dated - about a month old so the situation may have changed since them: https://calgary.ctvnews.ca/calgary-s-covid-19-field-hospital-hasn-t-seen-a-single-patient-with-the-illness-1.5160187
Comment by StevenBirch on Nov 24, 2020 8:06pm
Another Canadian covid story as today Trudeau says "one of the things to remember is Canada no longer has any domestic production capacity for vaccines". That's all.
Comment by Pandora on Nov 24, 2020 9:32pm
Trudeau made a statement today that Canada will be behind most of it's allies in procuring the new vaccines supposedly because we do not have a vaccine manufacturing facility in the country. In the meantime Gov’t of Canada is on the hunt for promising therapeutics. PM Trudeau stated on Nov 24: ‘to keep Canadians safe, we need access to as many potential vaccines and treatments as possible ...more  
Comment by Yajne on Nov 24, 2020 10:17pm
IMO, never NEVER underestimate the influence that BigPharma has with HC, what moves quickly and what moves slowly, if at all. Unfortunately it appears that SONA has also become a victim of this, hopefully TLT can find a way to clear the obstacles seemingly reserved for smaller firms. Guessing that my opinion on this will get me suspended once again, but that would pretty much confirm how this ...more  
Comment by Rumpl3StiltSkin on Nov 24, 2020 11:20pm
I think this could be a problem IF TLT can't get the message through to Trudeau's people that they have a great therapeutic AND a probable vaccine.
Comment by Rumpl3StiltSkin on Nov 24, 2020 9:32pm
Well, Maybe TLT will get to set him straight soon? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250